Researchers have developed a DNA-based therapy that targets the PCSK9 gene to lower cholesterol naturally. Using polypurine ...

Texas A&M Health researchers discovered that RNA drives cancer growth in translocation renal cell carcinoma (tRCC) by ...

Texas A&M researchers found that in an aggressive kidney cancer, RNA builds “droplet hubs” that activate tumor genes. By creating a molecular switch to dissolve these hubs, they stopped cancer growth ...

NASA’s discovery of potential evidence of ancient life on Mars means “our galaxy could be teeming with life,” says a ...

The goal of gene therapy is to permanently cure hereditary diseases. One of the most promising technologies for this is the ...

St. Jude researchers advance CASTs, enhancing precision and activity for next-generation genome-editing therapies.

Dr Katherine Ruzhansky previews presentations on biomarkers, new therapies, and translational science at AANEM 2025.

Founded in 2018, Metagenomi is using a Nobel prize-winning approach developed by Jennifer Doudna and Emmanuelle Charpentier ...

This study presents a useful inventory of genes that are up- and down-regulated in the mouse small intestine (duodenum and ileum) during the first postnatal month; the data were collected and analyzed ...

Jonathan Henninger, an assistant professor of biological sciences, is part of a growing movement in the life sciences ...

The first functional mirror-image pore has been created, capable of reducing the survival of aggressive breast cancer cells ...

Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering a new class of small molecule precision cancer therapies, today announced new preclinical data on its two lead programs: the ...